- June 29, 2021
- Posted by: Stratford Team
- Category: Business
Palatin Technologies Inc., the Cranbury-based biopharmaceutical company, has named three new senior executives, it announced Monday.
The company said it has appointed Dr. Michael B. Raizman as chief medical officer, James E. Hattersley as senior vice president of business development and J. Don Wang as vice president of product development.
“We are proud that we continue to attract the best and brightest minds who share our passion and approach to bringing impactful treatments to patients,” CEO and President Carl Spana said in a prepared statement. “We are at a critical stage in the advancement of our inflammatory and autoimmune programs, and we believe Dr. Raizman, Mr. Hattersley and Dr. Wang will significantly aid the company in responding to the evolving challenges in the market with agility, expertise and determination.”
Raizman, a physician specializing in ophthalmology, will provide leadership and direction…
